Skip to content
Open Menu icon
  • About
    • Advocacy & Policy
    • About Us
    • Team & Board
    • Generic Medicines
    • Our Members
  • Advocacy & Policy
    • Federal Advocacy
    • State Advocacy
    • Tariff & Trade
    • Biosimilars
    • GDUFA/BsUFA User Fees
    • IP & Patent Reform
    • Inflation Reduction Act
    • Medicaid Generics Penalty
  • Resources
    • Generic & Biosimilar
      Medicines Savings Report
    • Advocacy Priorities
    • Biosimilars
    • Resource Center
  • Events
    • All Events
    • GRx+Biosims 2026
    • Access! 2027
  • About
    • Advocacy & Policy
    • About Us
    • Team & Board
    • Generic Medicines
    • Our Members
  • Advocacy & Policy
    • Federal Advocacy
    • State Advocacy
    • Tariff & Trade
    • Biosimilars
    • GDUFA/BsUFA User Fees
    • IP & Patent Reform
    • Inflation Reduction Act
    • Medicaid Generics Penalty
  • Resources
    • Generic & Biosimilar
      Medicines Savings Report
    • Advocacy Priorities
    • Biosimilars
    • Resource Center
  • Events
    • All Events
    • GRx+Biosims 2026
    • Access! 2027
JOIN
SEARCH
Home
Resources
Video
The CREATES Act – A Conservative Market-based Solution to Lower Drug Prices

The CREATES Act – A Conservative Market-based Solution to Lower Drug Prices

Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
  • 202.249.7100
  • info@accessiblemeds.org

About Us

  • About AAM
  • Biosimilars Council
  • Community Commitment
  • Our Team
  • Meet Our Board
  • About Generics
  • Our Members
  • Careers
  • Contact Us

ADVOCACY & POLICY

  • Overview
  • Federal Advocacy
  • State Advocacy
  • Tariffs & Trade
  • Biosimilars
  • GDUFA/BsUFA User Fees
  • IP & Patent Reform
  • Inflation Reduction Act
  • Medicaid Generics Penalty

Resources

  • Resource Portal
  • Press Releases
  • Savings Report
  • Advocacy Priorities
  • Blog
  • Founders Blogs
  • Amicus Briefs
  • Patient Stories
  • Generic Medicines FAQ

Events

  • GRx+Biosims
  • Access!
  • All Events

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe

© 2026 Association for Accessible Medicines (AAM), All Rights Reserved
Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram
  • Resources
    • 2025 Savings Report
    • 2025 Advocacy Priorities
    • 2025 First Generics White Paper
    • Drug Shortages White Paper
    • Biosimilars Patient Resource Center
    • Biosimilar Research & Studies
    • Blog
    • Founders Blogs
    • Amicus Briefs
    • Patient Stories
  • About the Association
    • Generic Quality
    • About AAM
    • Our Team
    • Our Members
    • Generic Medicines
    • Biosimilars Council
    • Meet Our Board
    • Community Commitment
    • Careers
    • Contact Us
  • Advocacy & Policy
    • Federal Advocacy
    • Biosimilars
    • GDUFA/BsUFA User Fees
    • Inflation Reduction Act
    • Intellectual Property & Patent Reform
    • Medicaid Generics Penalty
    • State Advocacy
    • Tariffs & Trade
  • Events
    • Access! 2026
    • GRx+Biosims 2026
  • Press Releases
  • JOIN
  • About
    • Advocacy & Policy
    • About Us
    • Team & Board
    • Generic Medicines
    • Our Members
  • Advocacy & Policy
    • Federal Advocacy
    • State Advocacy
    • Tariff & Trade
    • Biosimilars
    • GDUFA/BsUFA User Fees
    • IP & Patent Reform
    • Inflation Reduction Act
    • Medicaid Generics Penalty
  • Resources
    • Generic & Biosimilar
      Medicines Savings Report
    • Advocacy Priorities
    • Biosimilars
    • Resource Center
  • Events
    • All Events
    • GRx+Biosims 2026
    • Access! 2027
JOIN
SEARCH